Table 5 Factors related to sexual exposures and reproduction in relation to high anti-HHV-8 antibody titers
high titer/total pos (%)¥ | aOR * 95%CI | |
|---|---|---|
Number of lifetime husbands/wives | ||
0–1§ | 247/633 (39.0) | 1.0 |
≥ 2 | 20/45 (44.4) | 1.26 (0.68–2.35) |
Test for Trend¶ | χ2 = 0.55, p = 0.46 | |
Marital status | ||
Single§ | 51/175 (29.1) | 1.0 |
Married | 166/458 (36.2) | 1.11 (0.73–1.69) |
Widowed | 75/162 (46.3) | 1.54 (0.92–2.59) |
Separated/Divorced | 31/57 (54.4) | 2.44 (1.30–4.58) |
Test of Homogeneity¶ (3 df) | χ2 = 10.6, p = 0.01 | |
Number of lifetime sexual partners | ||
0–2§ | 64/166 (38.6) | 1.0 |
3–4 | 156/423 (36.9) | 0.94 (0.65–1.38) |
≥ 5 | 79/202 (39.1) | 1.11 (0.71–1.74) |
Test for Trend¶ | χ2 = 0.37, p = 0.54 | |
Pregnant (in lifetime) | ||
Yes§ | 189/501 (37.7) | 1.0 |
No | 8/17 (47.1) | 1.65 (0.61–4.49) |
Test of Homogeneity¶ | χ2 = 0.95, p = 0.33 | |
Times pregnant (in lifetime) | ||
1§ | 11/39 (28.2) | 1.0 |
2–3 | 57/149 (38.3) | 1.69 (0.77–3.69) |
4–5 | 54/142 (38.0) | 1.50 (0.68–3.29) |
≥ 6 | 68/173 (39.3) | 1.45 (0.67–3.15) |
Test for Trend¶ | χ2 = 0.03, p = 0.87 | |
Times miscarriage (in lifetime) | ||
0§ | 6/12 (50.0) | 1.0 |
1 | 37/107 (34.6) | 0.56 (0.17–1.89) |
≥ 2 | 39/100 (39.0) | 0.61 (0.18–2.06) |
Test for Trend¶ | χ2 = 0.10, p = 0.73 | |
Parity | ||
0–2§ | 53/140 (37.9) | 1.0 |
3–4 | 57/174 (32.8) | 0.73 (0.45–1.18) |
≥ 5 | 74/176 (42.1) | 0.99 (0.62–1.59) |
Test for Trend¶ | χ2 = 0.00, p = 0.95 | |
Number of children (born alive) (for men) | ||
0–1§ | 10/26 (38.5) | 1.0 |
2–3 | 29/82 (35.4) | 0.80 (0.31–2.06) |
4–5 | 31/80 (38.8) | 0.76 (0.29–2.01) |
≥ 6 | 49/126 (38.9) | 0.69 (0.26–1.79) |
Test for Trend¶ | χ2 = 0.50, p = 0.48 | |
Number of mothers and fathers (children) | ||
1§ | 237/608 (39.0) | 1.0 |
≥ 2 | 67/197 (34.0) | 0.82 (0.58–1.16) |
Test for Trend¶ | χ2 = 1.30, p = 0.25 | |
Age when periods began | ||
10–13§ | 17/39 (43.6) | 1.0 |
14 | 34/81 (42.0) | 0.93 (0.42–2.04) |
15 | 53/166 (31.9) | 0.55 (0.27–1.14) |
≥ 16 | 91/227 (40.1) | 0.77 (0.38–1.56) |
Test for Trend¶ | χ2 = 0.46, p = 0.50 | |
Age when periods ended | ||
≤ 45§ | 32/94 (34.0) | 1.0 |
46–49 | 40/100 (40.0) | 1.11(0.60–2.08) |
≥ 50 | 85/198 (42.9) | 1.24 (0.69–2.23) |
Test for Trend¶ | χ2 = 0.74, p = 0.39 | |
Oral contraceptives | ||
No§ | 168/424 (39.6) | 1.0 |
Yes | 25/86 (29.1) | 0.69 (0.40–1.17) |
Test of Homogeneity¶ | χ2 = 1.88, p = 0.17 | |
Injectable contraceptives | ||
No§ | 165/425 (38.8) | 1.0 |
Yes | 28/87 (32.2) | 0.93 (0.55–1.59) |
Test of Homogeneity¶ | χ2 = 0.07, p = 0.80 |